Tarsus Pharmaceuticals Inc. (TARS) NASDAQ

$35.02 (1.15) (-3.18%)

Market Cap: $1.24B

As of 04/15/24 03:59 PM EDT. Market closed.

(TARS)

Tarsus Pharmaceuticals Inc. (TARS)
NASDAQ

$35.02
(1.15) (-3.18%)

Market Cap: $1.24B

As of 04/15/24 03:59 PM EDT. Market closed.

Add to Portfolio

tarsus pharmaceuticals, inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. its lead product candidate is tp-03, a novel therapeutic that is in phase iib/iii for the treatment of blepharitis caused by the infestation of demodex mites, as well as to treat meibomian gland disease. the company ... read more

tarsus pharmaceuticals, inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. its lead product candidate is tp-03, a novel therapeutic that is in phase iib/iii for the treatment of blepharitis caused by the infestation of demodex mites, as well as to treat meibomian gland disease. the company is also developing tp-04 for the treatment of rosacea; and tp-05 for lyme prophylaxis and community malaria reduction. tarsus pharmaceuticals, inc. was founded in 2016 and is headquartered in irvine, california. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Full Time Employees
104
Address
.
PRICE CHART FOR TARSUS PHARMACEUTICALS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$36.53
Previous Close
$36.17
Days Range
$35.20 - $38.23
52 week range
$11.33 - $40.40
Volume
328,108
Avg. Volume (30 days)
598,789
Market Cap
$1.24B
Dividend Yield
-
P/E
(9.11)
Shares Outstanding
34,218,886
Open
$36.53
Previous Close
$36.17
Days Range
$35.20 - $38.23
52 week range
$11.33 - $40.40
Volume
328,108
Avg. Volume (30 days)
598,789
Market Cap
$1.24B
Dividend Yield
-
P/E
(9.11)
Shares Outstanding
34,218,886
FINANCIAL STATEMENTS FOR TARSUS PHARMACEUTICALS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR TARSUS PHARMACEUTICALS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Mottiwala AzizChief Commercial OfficerMar 18, 2024 Sale$30.604,766145,84054,075Mar 19, 2024, 07:08 PM
Wahl BryanGeneral CounselMar 18, 2024 Sale$30.604,436135,74240,951Mar 19, 2024, 07:05 PM
Azamian Bobak R.President/CEO and Board ChairMar 18, 2024 Sale$30.6010,415318,69926,456Mar 19, 2024, 07:05 PM
Whitfield Dianne C.Chief Human Resources OfficerMar 18, 2024 Sale$30.604,314132,00834,181Mar 19, 2024, 07:04 PM
Neervannan SeshadriChief Operating OfficerMar 18, 2024 Sale$30.604,879149,29764,767Mar 19, 2024, 07:03 PM
Azamian Bobak R.President/CEO and Board ChairDec 27, 2023 Sale$20.228,000161,760830,106Dec 29, 2023, 05:08 PM
Trevejo Jose M.CHIEF MEDICAL OFFICERDec 20, 2023 Sale$20.002,25245,0402,251Dec 22, 2023, 05:32 PM
Azamian Bobak R.President/CEO and Board ChairDec 20, 2023 Sale$20.2740,000810,623868,663Dec 22, 2023, 05:30 PM
Goldberg Andrew D.DirectorDec 15, 2023 Buy$18.961,00018,9603,000Dec 19, 2023, 06:30 PM
Whitfield Dianne C.Chief Human Resources OfficerNov 30, 2023 Sale$16.318,355136,27026,784Dec 01, 2023, 04:58 PM
Wahl BryanGeneral CounselNov 30, 2023 Sale$16.318,356136,28631,966Dec 01, 2023, 04:55 PM
Azamian Bobak R.President/CEO and Board ChairNov 15, 2023 Sale$18.378,000146,933883,210Nov 17, 2023, 04:50 PM
Azamian Bobak R.President/CEO and Board ChairOct 18, 2023 Sale$13.248,000105,920886,106Oct 20, 2023, 04:41 PM
Trevejo Jose M.CHIEF MEDICAL OFFICEROct 05, 2023 Sale$18.001,60428,8724,503Oct 06, 2023, 05:21 PM
Azamian Bobak R.President/CEO and Board ChairSep 20, 2023 Sale$17.218,000137,680894,106Sep 22, 2023, 05:30 PM
Azamian Bobak R.President/CEO and Board ChairAug 23, 2023 Sale$17.238,000137,840902,106Aug 25, 2023, 05:12 PM
Lin Elizabeth YeuDirectorAug 15, 2023 Buy$16.809,506159,70115,866Aug 17, 2023, 06:02 PM
Mottiwala AzizChief Commercial OfficerJul 19, 2023 Sale$20.052,40048,12045,806Jul 21, 2023, 05:46 PM
Azamian Bobak R.President/CEO and Board ChairJul 19, 2023 Sale$20.01103,9002,078,9841,009,832Jul 21, 2023, 05:42 PM
Azamian Bobak R.President/CEO and Board ChairJul 12, 2023 Sale$17.359,000156,1501,014,006Jul 14, 2023, 04:40 PM
Azamian Bobak R.President/CEO and Board ChairJun 21, 2023 Sale$18.638,000149,0401,023,006Jun 23, 2023, 04:29 PM
Azamian Bobak R.President/CEO and Board ChairJun 14, 2023 Sale$18.589,000167,2201,031,006Jun 16, 2023, 04:48 PM
Azamian Bobak R.President/CEO and Board ChairJun 08, 2023 Sale$20.013,10062,0311,040,006Jun 12, 2023, 05:40 PM
Mottiwala AzizChief Commercial OfficerJun 08, 2023 Sale$20.001002,00048,086Jun 12, 2023, 05:25 PM
Mottiwala AzizChief Commercial OfficerJun 07, 2023 Sale$19.342,50048,35048,186Jun 08, 2023, 07:16 PM
Mottiwala AzizChief Commercial OfficerJun 06, 2023 Sale$18.612,14339,88150,686Jun 08, 2023, 07:16 PM
Azamian Bobak R.President/CEO and Board ChairMay 17, 2023 Sale$15.908,000127,2001,043,106May 19, 2023, 07:08 PM
Azamian Bobak R.President/CEO and Board ChairMay 10, 2023 Sale$16.809,000151,2001,051,106May 12, 2023, 05:08 PM
Azamian Bobak R.President/CEO and Board ChairMay 01, 2023 Sale$15.105,84188,1991,060,106May 02, 2023, 07:06 PM
Azamian Bobak R.President/CEO and Board ChairApr 28, 2023 Sale$15.134,27864,7261,065,947May 02, 2023, 07:06 PM
Azamian Bobak R.President/CEO and Board ChairApr 21, 2023 Sale$15.032,31134,7341,070,225Apr 25, 2023, 05:22 PM
Greenstein Leonard M.Chief Financial OfficerApr 20, 2023 Sale$14.025,00070,10026,785Apr 21, 2023, 05:53 PM
Azamian Bobak R.President/CEO and Board ChairApr 19, 2023 Sale$13.608,000108,8001,072,536Apr 21, 2023, 05:49 PM
Greenstein Leonard M.Chief Financial OfficerMar 21, 2023 Sale$12.893264,20232,463Mar 23, 2023, 08:04 PM
Greenstein Leonard M.Chief Financial OfficerMar 23, 2023 Sale$12.153464,20431,785Mar 23, 2023, 08:04 PM
Greenstein Leonard M.Chief Financial OfficerMar 22, 2023 Sale$12.643324,19632,131Mar 23, 2023, 08:04 PM
Trevejo Jose M.CHIEF MEDICAL OFFICERMar 23, 2023 Sale$12.154655,6506,107Mar 23, 2023, 08:02 PM
Trevejo Jose M.CHIEF MEDICAL OFFICERMar 22, 2023 Sale$12.645296,6876,572Mar 23, 2023, 08:02 PM
Trevejo Jose M.CHIEF MEDICAL OFFICERMar 21, 2023 Sale$12.895196,6907,101Mar 23, 2023, 08:02 PM
Neervannan SeshadriChief Operating OfficerMar 21, 2023 Sale$12.893724,79555,465Mar 23, 2023, 07:56 PM
Neervannan SeshadriChief Operating OfficerMar 23, 2023 Sale$12.153904,73854,696Mar 23, 2023, 07:56 PM
Neervannan SeshadriChief Operating OfficerMar 22, 2023 Sale$12.643794,79155,086Mar 23, 2023, 07:56 PM
Wahl BryanGeneral CounselMar 23, 2023 Sale$12.153714,50816,402Mar 23, 2023, 07:52 PM
Wahl BryanGeneral CounselMar 22, 2023 Sale$12.643574,51216,773Mar 23, 2023, 07:52 PM
Wahl BryanGeneral CounselMar 21, 2023 Sale$12.893504,51217,130Mar 23, 2023, 07:52 PM
Azamian Bobak R.President/CEO and Board ChairMar 23, 2023 Sale$12.157378,9558,597Mar 23, 2023, 07:50 PM
Azamian Bobak R.President/CEO and Board ChairMar 22, 2023 Sale$12.647098,9629,334Mar 23, 2023, 07:50 PM
Azamian Bobak R.President/CEO and Board ChairMar 21, 2023 Sale$12.896798,75210,043Mar 23, 2023, 07:50 PM
Whitfield Dianne C.Chief Human Resources OfficerMar 23, 2023 Sale$12.153454,19211,219Mar 23, 2023, 07:48 PM
Whitfield Dianne C.Chief Human Resources OfficerMar 22, 2023 Sale$12.643334,20911,564Mar 23, 2023, 07:48 PM
Whitfield Dianne C.Chief Human Resources OfficerMar 21, 2023 Sale$12.893264,20211,897Mar 23, 2023, 07:48 PM
Mottiwala AzizChief Commercial OfficerMar 23, 2023 Sale$12.153724,52052,829Mar 23, 2023, 07:46 PM
Mottiwala AzizChief Commercial OfficerMar 22, 2023 Sale$12.643574,51253,201Mar 23, 2023, 07:46 PM
Mottiwala AzizChief Commercial OfficerMar 21, 2023 Sale$12.893494,49953,558Mar 23, 2023, 07:46 PM
Whitfield Dianne C.Chief Human Resources OfficerMar 20, 2023 Sale$12.613334,19912,223Mar 21, 2023, 07:17 PM
Whitfield Dianne C.Chief Human Resources OfficerMar 17, 2023 Sale$13.283164,19612,556Mar 21, 2023, 07:17 PM
Wahl BryanGeneral CounselMar 20, 2023 Sale$12.613574,50217,480Mar 21, 2023, 07:14 PM
Wahl BryanGeneral CounselMar 17, 2023 Sale$13.283394,50217,837Mar 21, 2023, 07:14 PM
Neervannan SeshadriChief Operating OfficerMar 20, 2023 Sale$12.613804,79255,837Mar 21, 2023, 07:12 PM
Neervannan SeshadriChief Operating OfficerMar 17, 2023 Sale$13.283604,78156,217Mar 21, 2023, 07:12 PM
Trevejo Jose M.CHIEF MEDICAL OFFICERMar 20, 2023 Sale$12.615306,6837,620Mar 21, 2023, 07:10 PM
Trevejo Jose M.CHIEF MEDICAL OFFICERMar 17, 2023 Sale$13.285046,6938,150Mar 21, 2023, 07:10 PM
Mottiwala AzizChief Commercial OfficerMar 20, 2023 Sale$12.613584,51453,907Mar 21, 2023, 07:08 PM
Mottiwala AzizChief Commercial OfficerMar 17, 2023 Sale$13.283394,50254,265Mar 21, 2023, 07:08 PM
Holdbrook Mark J.V.P., Clinical AffairsMar 20, 2023 Sale$12.611982,4973,191Mar 21, 2023, 07:06 PM
Holdbrook Mark J.V.P., Clinical AffairsMar 17, 2023 Sale$13.281882,4973,389Mar 21, 2023, 07:06 PM
Greenstein Leonard M.Chief Financial OfficerMar 17, 2023 Sale$13.283164,19633,122Mar 21, 2023, 07:03 PM
Greenstein Leonard M.Chief Financial OfficerMar 20, 2023 Sale$12.613334,19932,789Mar 21, 2023, 07:03 PM
Azamian Bobak R.President/CEO and Board ChairMar 20, 2023 Sale$12.617419,34410,722Mar 21, 2023, 07:01 PM
Azamian Bobak R.President/CEO and Board ChairMar 17, 2023 Sale$13.2879510,55811,463Mar 21, 2023, 07:01 PM
Holdbrook Mark J.V.P., Clinical AffairsMar 16, 2023 Sale$13.431872,5113,577Mar 17, 2023, 06:22 PM
Wahl BryanGeneral CounselMar 16, 2023 Sale$13.433374,52618,176Mar 17, 2023, 06:21 PM
Whitfield Dianne C.Chief Human Resources OfficerMar 16, 2023 Sale$13.433134,20412,872Mar 17, 2023, 06:20 PM
Trevejo Jose M.Chief Medical OfficerMar 16, 2023 Sale$13.434996,7028,654Mar 17, 2023, 06:18 PM
Mottiwala AzizChief Commercial OfficerMar 16, 2023 Sale$13.433364,51254,604Mar 17, 2023, 06:17 PM
Neervannan SeshadriChief Operating OfficerMar 16, 2023 Sale$13.433574,79556,577Mar 17, 2023, 06:15 PM
Greenstein Leonard M.Chief Financial OfficerMar 16, 2023 Sale$13.445,31371,40438,438Mar 17, 2023, 06:04 PM
Azamian Bobak R.President/CEO and Board ChairMar 16, 2023 Sale$13.4379110,62312,258Mar 17, 2023, 06:02 PM
Azamian Bobak R.President/CEO and Board ChairMar 15, 2023 Sale$13.798,000110,3201,080,536Mar 17, 2023, 06:02 PM
Azamian Bobak R.President/CEO and Board ChairMar 08, 2023 Sale$15.024,85372,8921,089,253Mar 10, 2023, 05:13 PM
Azamian Bobak R.President/CEO and Board ChairMar 09, 2023 Sale$15.0171710,7621,088,536Mar 10, 2023, 05:13 PM
Greenstein Leonard M.Chief Financial OfficerFeb 16, 2023 Sale$15.125,00075,60034,289Feb 17, 2023, 04:58 PM
Azamian Bobak R.President/CEO and Board ChairFeb 15, 2023 Sale$15.288,000122,2401,094,106Feb 17, 2023, 04:54 PM
Azamian Bobak R.President/CEO and Board ChairFeb 08, 2023 Sale$15.149,000136,2601,102,106Feb 10, 2023, 04:54 PM
Azamian Bobak R.President/CEO and Board ChairJan 23, 2023 Sale$15.454,85675,0251,111,106Jan 25, 2023, 05:49 PM
Azamian Bobak R.President/CEO and Board ChairJan 06, 2023 Sale$15.004116,1651,129,740Jan 24, 2023, 06:13 PM
Greenstein Leonard M.Chief Financial OfficerJan 19, 2023 Sale$14.565,00072,80039,289Jan 20, 2023, 06:44 PM
Azamian Bobak R.President/CEO and Board ChairJan 20, 2023 Sale$15.002403,6001,116,373Jan 20, 2023, 06:41 PM
Azamian Bobak R.President/CEO and Board ChairJan 18, 2023 Sale$14.568,000116,4801,116,613Jan 20, 2023, 06:41 PM
Azamian Bobak R.President/CEO and Board ChairJan 11, 2023 Sale$15.113,90458,9891,124,613Jan 13, 2023, 06:47 PM
Azamian Bobak R.President/CEO and Board ChairJan 10, 2023 Sale$15.1790513,7291,128,517Jan 11, 2023, 08:26 PM
Azamian Bobak R.President/CEO and Board ChairJan 09, 2023 Sale$15.1572911,0441,129,422Jan 11, 2023, 08:26 PM
Azamian Bobak R.President/CEO and Board ChairDec 21, 2022 Sale$14.578,000116,5601,130,151Dec 22, 2022, 06:02 PM
Azamian Bobak R.President/CEO and Board ChairDec 16, 2022 Sale$15.015358,0301,138,151Dec 20, 2022, 06:35 PM
Greenstein Leonard M.Chief Financial OfficerDec 15, 2022 Sale$14.645,00073,20044,289Dec 16, 2022, 04:55 PM
Azamian Bobak R.President/CEO and Board ChairDec 14, 2022 Sale$15.086,42096,8141,138,686Dec 16, 2022, 04:51 PM
Whitfield Dianne C.Chief Human Resources OfficerDec 02, 2022 Sale$16.901,15419,5038,723Dec 06, 2022, 05:52 PM
Wahl BryanGeneral CounselDec 02, 2022 Sale$16.901,15419,50313,723Dec 06, 2022, 05:49 PM
Whitfield Dianne C.Chief Human Resources OfficerDec 01, 2022 Sale$16.751,16519,5149,877Dec 01, 2022, 08:09 PM
Whitfield Dianne C.Chief Human Resources OfficerNov 30, 2022 Sale$16.501,18219,50311,042Dec 01, 2022, 08:09 PM
Wahl BryanGeneral CounselDec 01, 2022 Sale$16.751,16419,49714,877Dec 01, 2022, 07:58 PM
Wahl BryanGeneral CounselNov 30, 2022 Sale$16.501,18319,52016,041Dec 01, 2022, 07:58 PM
Greenstein Leonard M.Chief Financial OfficerNov 17, 2022 Sale$16.545,00082,70049,289Nov 18, 2022, 04:12 PM
Azamian Bobak R.President and CEONov 16, 2022 Sale$16.868,000134,8521,145,851Nov 18, 2022, 04:09 PM
Mottiwala AzizChief Commercial OfficerNov 15, 2022 Sale$17.726,857121,50649,729Nov 17, 2022, 05:30 PM
Azamian Bobak R.President and CEONov 09, 2022 Sale$17.879,000160,8301,153,106Nov 14, 2022, 04:25 PM
Greenstein Leonard M.Chief Financial OfficerOct 20, 2022 Sale$15.925,00079,58954,412Oct 28, 2022, 04:24 PM
Azamian Bobak R.President and CEOOct 19, 2022 Sale$16.928,000135,3491,162,206Oct 21, 2022, 04:23 PM
Azamian Bobak R.President and CEOOct 12, 2022 Sale$15.919,000143,1941,172,927Oct 14, 2022, 04:32 PM
Azamian Bobak R.President and CEOSep 21, 2022 Sale$16.318,000130,4741,179,206Sep 23, 2022, 06:08 PM
Greenstein Leonard M.Chief Financial OfficerSep 15, 2022 Sale$16.035,00080,15059,289Sep 16, 2022, 04:33 PM
Azamian Bobak R.President and CEOSep 14, 2022 Sale$16.019,000144,0901,187,106Sep 16, 2022, 04:28 PM
Lin Elizabeth YeuDirectorSep 14, 2022 Buy$16.296,360103,6046,360Sep 16, 2022, 04:24 PM
Lin Elizabeth YeuDirectorSep 14, 2022 Buy$16.0312,040193,00112,040Sep 16, 2022, 04:24 PM
Mottiwala AzizChief Commercial OfficerAug 24, 2022 Option Exercise$9.425,18848,87956,586Aug 26, 2022, 04:25 PM
Greenstein Leonard M.Chief Financial OfficerAug 18, 2022 Sale$16.305,00081,50064,289Aug 19, 2022, 04:52 PM
Azamian Bobak R.President and CEOAug 17, 2022 Sale$16.598,000132,6921,196,842Aug 19, 2022, 04:49 PM
Ackermann MichaelDirectorMay 05, 2022 Buy$13.50100,0001,350,000100,000May 09, 2022, 04:42 PM
Vivo Capital IX, LLC10% OwnerMay 05, 2022 Sale$12.255,37465,8322,469,001May 05, 2022, 06:55 PM
Vivo Capital IX, LLC10% OwnerMay 02, 2022 Sale$15.1941,800634,9422,945,531May 04, 2022, 08:01 PM
Vivo Capital IX, LLC10% OwnerMay 04, 2022 Sale$12.6719,738250,0802,474,375May 04, 2022, 08:01 PM
Vivo Capital IX, LLC10% OwnerMay 03, 2022 Sale$13.25451,4185,981,2892,494,113May 04, 2022, 08:01 PM
Ackermann MichaelDirectorDec 01, 2021 Sale$24.685,833143,9341,207,407Dec 03, 2021, 06:56 PM
Azamian Bobak R.President and CEODec 01, 2021 Sale$24.725,833144,1671,207,545Dec 03, 2021, 06:55 PM
Mottiwala AzizChief Commercial OfficerNov 08, 2021 Sale$28.111,88953,10050,203Nov 10, 2021, 06:29 PM
Mottiwala AzizChief Commercial OfficerNov 05, 2021 Sale$28.111130952,092Nov 08, 2021, 05:49 PM
Mottiwala AzizChief Commercial OfficerNov 04, 2021 Sale$28.031002,80352,103Nov 08, 2021, 05:49 PM
Mottiwala AzizChief Commercial OfficerNov 02, 2021 Sale$26.786,000160,69052,745Nov 04, 2021, 07:03 PM
Ackermann MichaelDirectorNov 01, 2021 Sale$27.825,833162,2891,210,718Nov 03, 2021, 07:00 PM
Azamian Bobak R.President and CEONov 01, 2021 Sale$27.825,833162,2841,210,739Nov 03, 2021, 06:55 PM
Ackermann MichaelDirectorOct 12, 2021 Sale$26.275,633148,0001,220,199Oct 14, 2021, 04:48 PM
Azamian Bobak R.President and CEOOct 12, 2021 Sale$26.305,531145,4481,220,470Oct 14, 2021, 04:44 PM
Ackermann MichaelDirectorOct 08, 2021 Sale$25.032005,0061,221,315Oct 12, 2021, 06:47 PM
Azamian Bobak R.President and CEOOct 08, 2021 Sale$25.023027,5551,221,303Oct 12, 2021, 06:43 PM
Mottiwala AzizChief Commercial OfficerSep 10, 2021 Option Exercise$7.056,94348,97360,796Sep 14, 2021, 04:51 PM
Mottiwala AzizChief Commercial OfficerSep 10, 2021 Sale$22.152,59357,43558,203Sep 14, 2021, 04:51 PM
Ackermann MichaelDirectorSep 01, 2021 Sale$25.245,833147,2371,221,515Sep 03, 2021, 06:53 PM
Azamian Bobak R.President and CEOSep 01, 2021 Sale$25.255,833147,3011,221,705Sep 03, 2021, 05:51 PM
Ackermann MichaelDirectorAug 11, 2021 Sale$25.1562115,6191,227,348Aug 12, 2021, 05:27 PM
Azamian Bobak R.President and CEOAug 10, 2021 Sale$25.001032,5751,229,355Aug 12, 2021, 05:26 PM
Azamian Bobak R.President and CEOAug 11, 2021 Sale$25.071,91748,0611,227,438Aug 12, 2021, 05:26 PM
Ackermann MichaelDirectorAug 09, 2021 Sale$25.0070017,5001,227,969Aug 10, 2021, 04:55 PM
Ackermann MichaelDirectorAug 06, 2021 Sale$25.003,12978,2251,228,669Aug 10, 2021, 04:55 PM
Azamian Bobak R.President and CEOAug 09, 2021 Sale$25.0282720,6881,229,558Aug 10, 2021, 04:53 PM
Azamian Bobak R.President and CEOAug 06, 2021 Sale$25.001,61640,4001,230,285Aug 10, 2021, 04:53 PM
Ackermann MichaelDirectorAug 05, 2021 Sale$25.001,38334,5761,231,998Aug 06, 2021, 04:16 PM
Azamian Bobak R.President and CEOAug 05, 2021 Sale$25.001,37034,2501,231,901Aug 06, 2021, 04:14 PM
Vivo Capital IX, LLC10% OwnerJun 25, 2021 Sale$29.607,704228,0382,987,331Jun 25, 2021, 09:30 PM
Vivo Capital IX, LLC10% OwnerJun 24, 2021 Sale$29.9010,000299,0002,995,035Jun 25, 2021, 09:30 PM
Vivo Capital IX, LLC10% OwnerJun 23, 2021 Sale$29.8037,9801,131,8043,005,035Jun 25, 2021, 09:30 PM
Vivo Capital IX, LLC10% OwnerJun 22, 2021 Sale$28.50110,0003,135,0003,043,015Jun 25, 2021, 08:51 PM
Vivo Capital IX, LLC10% OwnerJun 21, 2021 Sale$29.7091,6202,721,1143,153,015Jun 25, 2021, 08:51 PM
RTW INVESTMENTS, LP10% OwnerMay 07, 2021 Sale$29.98450,00013,491,0002,013,601May 07, 2021, 08:01 PM
Vivo Capital IX, LLC10% OwnerApr 14, 2021 Sale$30.3740012,1483,244,635Apr 16, 2021, 09:07 PM
Frazier Life Sciences IX, L.P.10% OwnerOct 20, 2020 Buy$16.00312,5005,000,0001,917,157Oct 20, 2020, 08:01 PM
Horowitz Limited Partnership VIII10% OwnerOct 20, 2020 Buy$16.0015,625250,00066,172Oct 20, 2020, 07:59 PM
Horowitz Limited Partnership VIII10% OwnerOct 20, 2020 Buy$16.00168,7502,700,0001,920,933Oct 20, 2020, 07:59 PM
Vivo Capital IX, LLC10% OwnerOct 20, 2020 Buy$16.00250,0004,000,0003,245,035Oct 20, 2020, 07:58 PM
Tester Jason E.DirectorOct 20, 2020 Buy$16.00168,7502,700,0001,920,933Oct 20, 2020, 07:56 PM
Tester Jason E.DirectorOct 20, 2020 Buy$16.003,12550,00028,398Oct 20, 2020, 07:56 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Mottiwala AzizChief Commercial Officer03/18/2024145,840
Wahl BryanGeneral Counsel03/18/2024135,742
Azamian Bobak R.President/CEO and Board Chair03/18/2024318,699
Whitfield Dianne C.Chief Human Resources Officer03/18/2024132,008
Neervannan SeshadriChief Operating Officer03/18/2024149,297
Azamian Bobak R.President/CEO and Board Chair12/27/2023161,760
Trevejo Jose M.CHIEF MEDICAL OFFICER12/20/202345,040
Azamian Bobak R.President/CEO and Board Chair12/20/2023810,623
Goldberg Andrew D.Director12/15/202318,960
Whitfield Dianne C.Chief Human Resources Officer11/30/2023136,270
Wahl BryanGeneral Counsel11/30/2023136,286
Azamian Bobak R.President/CEO and Board Chair11/15/2023146,933
Azamian Bobak R.President/CEO and Board Chair10/18/2023105,920
Trevejo Jose M.CHIEF MEDICAL OFFICER10/05/202328,872
Azamian Bobak R.President/CEO and Board Chair09/20/2023137,680
Azamian Bobak R.President/CEO and Board Chair08/23/2023137,840
Lin Elizabeth YeuDirector08/15/2023159,701
Mottiwala AzizChief Commercial Officer07/19/202348,120
Azamian Bobak R.President/CEO and Board Chair07/19/20232,078,984
Azamian Bobak R.President/CEO and Board Chair07/12/2023156,150
Azamian Bobak R.President/CEO and Board Chair06/21/2023149,040
Azamian Bobak R.President/CEO and Board Chair06/14/2023167,220
Azamian Bobak R.President/CEO and Board Chair06/08/202362,031
Mottiwala AzizChief Commercial Officer06/08/20232,000
Mottiwala AzizChief Commercial Officer06/07/202348,350
Mottiwala AzizChief Commercial Officer06/06/202339,881
Azamian Bobak R.President/CEO and Board Chair05/17/2023127,200
Azamian Bobak R.President/CEO and Board Chair05/10/2023151,200
Azamian Bobak R.President/CEO and Board Chair05/01/202388,199
Azamian Bobak R.President/CEO and Board Chair04/28/202364,726
Azamian Bobak R.President/CEO and Board Chair04/21/202334,734
Greenstein Leonard M.Chief Financial Officer04/20/202370,100
Azamian Bobak R.President/CEO and Board Chair04/19/2023108,800
Greenstein Leonard M.Chief Financial Officer03/21/20234,202
Greenstein Leonard M.Chief Financial Officer03/23/20234,204
Greenstein Leonard M.Chief Financial Officer03/22/20234,196
Trevejo Jose M.CHIEF MEDICAL OFFICER03/23/20235,650
Trevejo Jose M.CHIEF MEDICAL OFFICER03/22/20236,687
Trevejo Jose M.CHIEF MEDICAL OFFICER03/21/20236,690
Neervannan SeshadriChief Operating Officer03/21/20234,795
Neervannan SeshadriChief Operating Officer03/23/20234,738
Neervannan SeshadriChief Operating Officer03/22/20234,791
Wahl BryanGeneral Counsel03/23/20234,508
Wahl BryanGeneral Counsel03/22/20234,512
Wahl BryanGeneral Counsel03/21/20234,512
Azamian Bobak R.President/CEO and Board Chair03/23/20238,955
Azamian Bobak R.President/CEO and Board Chair03/22/20238,962
Azamian Bobak R.President/CEO and Board Chair03/21/20238,752
Whitfield Dianne C.Chief Human Resources Officer03/23/20234,192
Whitfield Dianne C.Chief Human Resources Officer03/22/20234,209
Whitfield Dianne C.Chief Human Resources Officer03/21/20234,202
Mottiwala AzizChief Commercial Officer03/23/20234,520
Mottiwala AzizChief Commercial Officer03/22/20234,512
Mottiwala AzizChief Commercial Officer03/21/20234,499
Whitfield Dianne C.Chief Human Resources Officer03/20/20234,199
Whitfield Dianne C.Chief Human Resources Officer03/17/20234,196
Wahl BryanGeneral Counsel03/20/20234,502
Wahl BryanGeneral Counsel03/17/20234,502
Neervannan SeshadriChief Operating Officer03/20/20234,792
Neervannan SeshadriChief Operating Officer03/17/20234,781
Trevejo Jose M.CHIEF MEDICAL OFFICER03/20/20236,683
Trevejo Jose M.CHIEF MEDICAL OFFICER03/17/20236,693
Mottiwala AzizChief Commercial Officer03/20/20234,514
Mottiwala AzizChief Commercial Officer03/17/20234,502
Holdbrook Mark J.V.P., Clinical Affairs03/20/20232,497
Holdbrook Mark J.V.P., Clinical Affairs03/17/20232,497
Greenstein Leonard M.Chief Financial Officer03/17/20234,196
Greenstein Leonard M.Chief Financial Officer03/20/20234,199
Azamian Bobak R.President/CEO and Board Chair03/20/20239,344
Azamian Bobak R.President/CEO and Board Chair03/17/202310,558
Holdbrook Mark J.V.P., Clinical Affairs03/16/20232,511
Wahl BryanGeneral Counsel03/16/20234,526
Whitfield Dianne C.Chief Human Resources Officer03/16/20234,204
Trevejo Jose M.Chief Medical Officer03/16/20236,702
Mottiwala AzizChief Commercial Officer03/16/20234,512
Neervannan SeshadriChief Operating Officer03/16/20234,795
Greenstein Leonard M.Chief Financial Officer03/16/202371,404
Azamian Bobak R.President/CEO and Board Chair03/16/202310,623
Azamian Bobak R.President/CEO and Board Chair03/15/2023110,320
Azamian Bobak R.President/CEO and Board Chair03/08/202372,892
Azamian Bobak R.President/CEO and Board Chair03/09/202310,762
Greenstein Leonard M.Chief Financial Officer02/16/202375,600
Azamian Bobak R.President/CEO and Board Chair02/15/2023122,240
Azamian Bobak R.President/CEO and Board Chair02/08/2023136,260
Azamian Bobak R.President/CEO and Board Chair01/23/202375,025
Azamian Bobak R.President/CEO and Board Chair01/06/20236,165
Greenstein Leonard M.Chief Financial Officer01/19/202372,800
Azamian Bobak R.President/CEO and Board Chair01/20/20233,600
Azamian Bobak R.President/CEO and Board Chair01/18/2023116,480
Azamian Bobak R.President/CEO and Board Chair01/11/202358,989
Azamian Bobak R.President/CEO and Board Chair01/10/202313,729
Azamian Bobak R.President/CEO and Board Chair01/09/202311,044
Azamian Bobak R.President/CEO and Board Chair12/21/2022116,560
Azamian Bobak R.President/CEO and Board Chair12/16/20228,030
Greenstein Leonard M.Chief Financial Officer12/15/202273,200
Azamian Bobak R.President/CEO and Board Chair12/14/202296,814
Whitfield Dianne C.Chief Human Resources Officer12/02/202219,503
Wahl BryanGeneral Counsel12/02/202219,503
Whitfield Dianne C.Chief Human Resources Officer12/01/202219,514
Whitfield Dianne C.Chief Human Resources Officer11/30/202219,503
Wahl BryanGeneral Counsel12/01/202219,497
Wahl BryanGeneral Counsel11/30/202219,520
Greenstein Leonard M.Chief Financial Officer11/17/202282,700
Azamian Bobak R.President and CEO11/16/2022134,852
Mottiwala AzizChief Commercial Officer11/15/2022121,506
Azamian Bobak R.President and CEO11/09/2022160,830
Greenstein Leonard M.Chief Financial Officer10/20/202279,589
Azamian Bobak R.President and CEO10/19/2022135,349
Azamian Bobak R.President and CEO10/12/2022143,194
Azamian Bobak R.President and CEO09/21/2022130,474
Greenstein Leonard M.Chief Financial Officer09/15/202280,150
Azamian Bobak R.President and CEO09/14/2022144,090
Lin Elizabeth YeuDirector09/14/2022103,604
Lin Elizabeth YeuDirector09/14/2022193,001
Mottiwala AzizChief Commercial Officer08/24/202248,879
Greenstein Leonard M.Chief Financial Officer08/18/202281,500
Azamian Bobak R.President and CEO08/17/2022132,692
Ackermann MichaelDirector05/05/20221,350,000
Vivo Capital IX, LLC10% Owner05/05/202265,832
Vivo Capital IX, LLC10% Owner05/02/2022634,942
Vivo Capital IX, LLC10% Owner05/04/2022250,080
Vivo Capital IX, LLC10% Owner05/03/20225,981,289
Ackermann MichaelDirector12/01/2021143,934
Azamian Bobak R.President and CEO12/01/2021144,167
Mottiwala AzizChief Commercial Officer11/08/202153,100
Mottiwala AzizChief Commercial Officer11/05/2021309
Mottiwala AzizChief Commercial Officer11/04/20212,803
Mottiwala AzizChief Commercial Officer11/02/2021160,690
Ackermann MichaelDirector11/01/2021162,289
Azamian Bobak R.President and CEO11/01/2021162,284
Ackermann MichaelDirector10/12/2021148,000
Azamian Bobak R.President and CEO10/12/2021145,448
Ackermann MichaelDirector10/08/20215,006
Azamian Bobak R.President and CEO10/08/20217,555
Mottiwala AzizChief Commercial Officer09/10/202148,973
Mottiwala AzizChief Commercial Officer09/10/202157,435
Ackermann MichaelDirector09/01/2021147,237
Azamian Bobak R.President and CEO09/01/2021147,301
Ackermann MichaelDirector08/11/202115,619
Azamian Bobak R.President and CEO08/10/20212,575
Azamian Bobak R.President and CEO08/11/202148,061
Ackermann MichaelDirector08/09/202117,500
Ackermann MichaelDirector08/06/202178,225
Azamian Bobak R.President and CEO08/09/202120,688
Azamian Bobak R.President and CEO08/06/202140,400
Ackermann MichaelDirector08/05/202134,576
Azamian Bobak R.President and CEO08/05/202134,250
Vivo Capital IX, LLC10% Owner06/25/2021228,038
Vivo Capital IX, LLC10% Owner06/24/2021299,000
Vivo Capital IX, LLC10% Owner06/23/20211,131,804
Vivo Capital IX, LLC10% Owner06/22/20213,135,000
Vivo Capital IX, LLC10% Owner06/21/20212,721,114
RTW INVESTMENTS, LP10% Owner05/07/202113,491,000
Vivo Capital IX, LLC10% Owner04/14/202112,148
Frazier Life Sciences IX, L.P.10% Owner10/20/20205,000,000
Horowitz Limited Partnership VIII10% Owner10/20/2020250,000
Horowitz Limited Partnership VIII10% Owner10/20/20202,700,000
Vivo Capital IX, LLC10% Owner10/20/20204,000,000
Tester Jason E.Director10/20/20202,700,000
Tester Jason E.Director10/20/202050,000
Load More Insider Transactions
FUNDS WITH A POSITION IN TARSUS PHARMACEUTICALS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.2,516,1390.0013%13.84%Other
VIVO CAPITAL, LLC1,784,0062.96%-21.14%Other
TFG ASSET MANAGEMENT GP LTD800,0003.9%30.08%Event Driven, Other
GEODE CAPITAL MANAGEMENT, LLC609,7360.00129%15.86%Other
D. E. SHAW & CO., INC.40,5270.00072%NewOther
ALPS ADVISORS INC21,8270.00348%-9.45%Other
CHANGE IN SHARES OUTSTANDING FOR TARSUS PHARMACEUTICALS INC
STOCK BUYBACKS FOR TARSUS PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
8.86%
1Q
12/31/2023
06/30/2023
24.32%
2Q
12/31/2023
03/31/2023
24.66%
3Q
12/31/2023
12/31/2022
24.82%
4Q
12/31/2023
09/30/2022
25.03%
5Q
12/31/2023
06/30/2022
37.01%
6Q
12/31/2023
03/31/2022
60.97%
7Q
12/31/2023
12/31/2021
62.19%
8Q
12/31/2023
09/30/2021
61.51%
9Q
12/31/2023
06/30/2021
51.76%
10Q
12/31/2023
03/31/2021
52.75%
11Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
8.86%
1Q
06/30/2023
24.32%
2Q
03/31/2023
24.66%
3Q
12/31/2022
24.82%
4Q
09/30/2022
25.03%
5Q
06/30/2022
37.01%
6Q
03/31/2022
60.97%
7Q
12/31/2021
62.19%
8Q
09/30/2021
61.51%
9Q
06/30/2021
51.76%
10Q
03/31/2021
52.75%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR TARSUS PHARMACEUTICALS INC
LOADING...